Lupin inches up on acquiring Huminsulin from Lilly to enhance diabetes portfolio

31 Dec 2024 Evaluate

Lupin is currently trading at Rs. 2316.00, up by 6.35 points or 0.27% from its previous closing of Rs. 2309.65 on the BSE.

The scrip opened at Rs. 2309.65 and has touched a high and low of Rs. 2342.90 and Rs. 2298.90 respectively. So far 30146 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2,342.90 on 31-Dec-2024 and a 52 week low of Rs. 1307.70 on 01-Jan-2024.

Last one week high and low of the scrip stood at Rs. 2342.90 and Rs. 2158.75 respectively. The current market cap of the company is Rs. 105018.35 crore.

The promoters holding in the company stood at 46.96%, while Institutions and Non-Institutions held 46.60% and 6.44% respectively.

Lupin has acquired Huminsulin in India from Eli Lilly and Company (Lilly) to further enhance its diabetes portfolio. Lupin has been marketing the Huminsulin range of products comprising of Insulin Human, including Huminsulin R, Huminsulin NPH, Huminsulin 50/50, and Huminsulin 30/70, through existing Distribution and Promotion Agreements with Lilly, India.

The Huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and children. Insulin treatment is the cornerstone of type 1 diabetes management and often becomes necessary over time in type 2 diabetes as the disease progresses. There is a significant Indian population affected with diabetes for both Type 1 and Type 2 Diabetes Mellitus, where Insulin Human is prescribed for management along with other concomitant therapies.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2078.05 -34.90 (-1.65%)
29-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.30
Dr. Reddys Lab 1268.00
Cipla 1493.10
Zydus Lifesciences 904.25
Lupin 2078.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×